Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Invion Limited runs a Biotechnology Research operation from South Melbourne, Victoria. It is publicly held, and its site is inviongroup.com. It holds one address on record, all in Australia. Headcount on record is 9. Tagged clinical-stage pharmaceutical drug development, FDA-regulated clinical trial design and asthma and COPD. One Australian registration (ABN) is a confirmed match. The record links seven similar brands, most of them in Biotechnology Research.
ABN76094730417
| INVION LIMITED | ABN 76094730417 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Invion is a clinical-stage life-sciences company that is leading the global clinical development of the Photosoft™ technology for the treatment of cancers. Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of Photosoft™. The appointment has been made by technology licensor, The Cho Group, a Hong Kong based group that has funded and successfully commercialised a number of unique and advanced technologies. Via an R&D services agreement between the two entities, the research and clinical trials of Photosoft™ are funded by The Cho Group. Invion has an alliance with leading Australian medical research institute, Hudson Institute of Medical Research, for the Photosoft™ research program.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Victoria entity on the ABR: INVION LIMITED (ABN 76 094 730 417), high confidence.
9 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: 100 Albert Rd, South Melbourne, Victoria 3205.
None linked to this brand.
Four tags on the brand's own list, among them Clinical-stage pharmaceutical drug development, FDA-regulated clinical trial design and asthma and COPD.
5 profiles list Invion Limited as a peer — 62nd percentile in Biotechnology Research. It lists ten peers of its own. VivaZome Therapeutics and Oncology One Pty Ltd list it back.